Finance

Lists
Why is 301393 up 3.01%?
Dive Deeper
301393:SHE
Suzhou Highfine Biotech Co Ltd
CNÂ¥61.18
+3.01%
(+1.79) 1D
Oct 20, 3:04:52 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301393...
Open
CNÂ¥59.20
High
CNÂ¥61.96
Low
CNÂ¥58.39
Mkt. cap
6.41B
Avg. vol.
3.26M
Volume
3.13M
Dividend
0.66%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 21, 2026
P/E ratio
60.15
52-wk high
CNÂ¥74.68
52-wk low
CNÂ¥46.69
EPS
CNÂ¥1.02
Shares outstanding
108.00M
No. of employees
678
Open
CNÂ¥59.20
High
CNÂ¥61.96
Low
CNÂ¥58.39
Mkt. cap
6.41B
Avg. vol.
3.26M
Volume
3.13M
Dividend
0.66%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 21, 2026
P/E ratio
60.15
52-wk high
CNÂ¥74.68
52-wk low
CNÂ¥46.69
EPS
CNÂ¥1.02
Shares outstanding
108.00M
No. of employees
678
News stories
From web sources and news partners
About Suzhou Highfine Biotech Co Ltd
CEO-
Employees678
FoundedDec 2, 2003
Headquarters-
SectorPharmaceutical industry
Websitehighfine.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
164.40M
167.56M
171.93M
207.29M
Cost of goods sold
104.78M
132.84M
110.89M
133.96M
Cost of revenue
104.78M
132.84M
110.89M
133.96M
Research and development expenses
11.35M
10.32M
10.69M
12.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.49M
9.78M
16.37M
16.91M
Operating expense
24.71M
31.28M
28.58M
34.07M
Total operating expenses
129.48M
164.13M
139.47M
168.04M
Operating income
34.92M
3.43M
32.47M
39.26M
Other non operating income
-5.48M
6.81M
-3.34M
2.23M
EBT including unusual items
26.71M
15.44M
37.63M
43.82M
EBT excluding unusual items
38.29M
11.00M
32.52M
38.32M
Income tax expense
3.35M
3.84M
4.92M
7.15M
Effective tax rate
12.56%
24.85%
13.06%
16.31%
Other operating expenses
-2.35M
7.73M
433.75K
2.71M
Net income
23.35M
15.41M
33.44M
37.30M
Net profit margin
14.21%
9.20%
19.45%
17.99%
Earnings per share
-
-
-
-
Interest and investment income
7.95M
8.28M
3.55M
2.07M
Interest expense
-454.89K
-193.75K
-152.49K
-163.90K
Net interest expenses
7.49M
8.09M
3.40M
1.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
39.48M
12.45M
41.48M
49.72M
Gain or loss from assets sale
-93.99K
907.51K
-
-124.54K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps